Moreover, this pathway reactivation is consistent with the pattern of RAS reactivation observed in other solid cancers and in BRAF V600E glioma lines upon adaptive resistance, underscoring the significance of RAS-ERK signaling for survival and proliferation in these gliomas. This evidence concerns the gene BRAF and central nervous system cancer.